Institutional Capital’s Novartis NVS Stock Holding History

Institutional Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,257,259	Closed	-$276M	–	56
2016 Q1	$276M	Sell	4,257,259 -890,868	-17%	-$60.6M	2.94%	21
2015 Q4	$397M	Buy	5,148,127 +864,835	+20%	+$68.7M	3.44%	9
2015 Q3	$353M	Buy	4,283,292 +2,551,724	+147%	+$227M	2.95%	16
2015 Q2	$153M	Buy	+1,731,568	New	+$159M	1.07%	33
2014 Q4	–	Sell	-910,320	Closed	-$76.8M	–	56
2014 Q3	$76.8M	Sell	910,320 -38,182	-4%	-$3.09M	0.45%	42
2014 Q2	$76.9M	Sell	948,502 -907,106	-49%	-$71.3M	0.36%	41
2014 Q1	$141M	Buy	1,855,608 +126,479	+7%	+$9.22M	0.67%	34
2013 Q4	$125M	Sell	1,729,129 -112,053	-6%	-$7.79M	0.6%	35
2013 Q3	$127M	Sell	1,841,182 -62,061	-3%	-$4.11M	0.65%	36
2013 Q2	$121M	Buy	+1,903,243	New	+$124M	0.62%	35

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Institutional Capital's NVS Position: Q2 2016 in Review

Institutional Capital sold out of Novartis (NVS) in Q2 2016, closing a stake of 4,257,259 shares — an estimated $276M sold.

Institutional Capital first reported a position in NVS in Q2 2013 and held it in 10 quarters. The position peaked at $397M in Q4 2015. 878 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

Institutional Capital reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
Institutional Capital sold 4,257,259 Novartis shares in Q2 2016, an estimated $276M.
Institutional Capital first reported a position in Novartis in Q2 2013 and held it in 10 quarters.
Institutional Capital's Novartis position peaked at $397M in Q4 2015.
878 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Institutional Capital's 13F filing for Q2 2016, filed 12 Aug 2016.